Navigation Links
Alexza Pharmaceuticals Files Shelf Registration Statement
Date:5/4/2010

ation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions.  Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation.  The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.  

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients.  Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials, submitted a New Drug Application submission in December 2009, and has a Prescription Drug User Fee Act (PDUFA) goal date of October 11, 2010.  In February 2010, Alexza established a partnership with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 in the U.S. and Canada.    

Alexza has completed an end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine) and has completed two Phase 2 studies with AZ-104 (Staccato loxapine, low-dose). Both product candidates are being developed for the acute treatment of migraine headache.  

<
'/>"/>
SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)...  Bayer Corporation hosted its annual "Take Your Child to ... US headquarters.  This is Bayer,s second "Take Your Child To ... campus, and Thursday,s event welcomed 230 children ready to ... Fortunately, for the kids, this was not just ... is "Science For A Better Life," Bayer made sure that ...
(Date:4/24/2015)... CHAPEL HILL, N.C. , April 24, 2015 ... marketplace, organizations are establishing employee groups around the ... workforce and round-the-clock business hours. While there are ... becoming global, leaders must examine which best practices ... global operational excellence. According to ...
(Date:4/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/pmbmv2/global_biobanking ) has ... 2015-2019" report to their offering. The ... a CAGR of 7.07% over the period 2014-2019 ... two segments: Equipment and Consumables. This report covers the ... Biobanking market for the period 2015-2019. ...
Breaking Medicine Technology:Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4Work Around the Clock: Building Effective Global Capabilities 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2
... ANGELES, Oct. 13, 2011 IVD Technology ... in vitro diagnostics technologies including research, development, and manufacturing, ... most significant emerging trend in the industry ... (CONTACT:   http://photos.prnewswire.com/prnh/20101214/LA16070LOGO ) The ...
... Oct. 13, 2011 PharmAthene, Inc. (NYSE Amex: ... brief in response to SIGA Technologies, motion for reargument.  On ... Chancery had issued a ruling in its litigation against SIGA ... years from all sales of ST-246 and related products after ...
Cached Medicine Technology:Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates 2Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates 3PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument 2PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument 3
(Date:4/25/2015)... New Jersey (PRWEB) April 25, 2015 ... people aged twelve and above needed treatment for an ... according to the Substance Abuse and Mental Health Services ... September 2011). Beyond these alarming numbers are harrowing stories ... by substance abuse . David H. Kerr ...
(Date:4/25/2015)... York, NY (PRWEB) April 25, 2015 By ... technology and data for the enterprise relying on their judgement ... running smoothly. But according to an article published ... can many times actually be doing a disservice to their ... i’s are dotted and t’s are crossed when it comes ...
(Date:4/25/2015)... Illinois (PRWEB) April 25, 2015 ... enrichment and wellness, management and operations, and sales ... Meeting and Exhibition scheduled to be held from ... , LeadingAge Illinois is the largest eldercare association ... providers of services for older adults, including senior ...
(Date:4/25/2015)... Sports controversies continue to revolve around issues of ... the case with the Miami Dolphins and Richie Incognito, or off ... Ray Rice domestic abuse case. In a recent episode of ... the implications of locker room culture on teams. He examines what ... should do to improve the locker room as a work place. ...
(Date:4/24/2015)... CA (PRWEB) April 24, 2015 Bird B ... and residential applications now offers a complete line of bird ... to poultry farms. , New Flu Strains Threaten Pacific, Central ... 2015 USDA post , a number of highly pathogenic ... paths. The disease is often spread when wild birds enter ...
Breaking Medicine News(10 mins):Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:David Steele Discusses Locker Room Culture on SCI TV 2Health News:David Steele Discusses Locker Room Culture on SCI TV 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4
... Insulet Corporation,(the "Company") (Nasdaq: PODD ) announced today ... aggregate principal amount of convertible senior,notes due 2013 (the ... on Rule 144A under the Securities Act of 1933, ... an option to,purchase up to an additional $10 million ...
... regulators and ... the healthcare industry, LANSDALE, ... appeal process is a big issue facing healthcare reform, says,NAIRO ... While 44 states and Washington, D.C. have external,review laws, each ...
... Headway, LLC (Medical Headway),is pleased to announce ... MedicalHeadway.com, dedicated to arming the public with ... of medicine. The company offers,consumers free and ... cutting-edge,professional medical treatment and product information., ...
... sleep time, even within the normal range, is associated ... naps, according to a research abstract that will be ... Meeting of the Associated Professional Sleep Societies (APSS). , ... of California at San Diego, focused on 24 healthy ...
... with Down Syndrome sleep poorly, with more fragmented sleep ... to a research abstract that will be presented on ... the Associated Professional Sleep Societies (APSS). , The study, ... of Michigan, focused on 38 children with Down Syndrome, ...
... are more likely to comply with continuous positive airway ... receive their treatment from a sleep center accredited by ... a research abstract that will be presented on Tuesday ... Associated Professional Sleep Societies (APSS). , The study, authored ...
Cached Medicine News:Health News:Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes 2Health News:Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes 3Health News:NAIRO Supports Uniform Health Carrier External Review Model Act Adopted by NAIC 2Health News:A New Home for Medical Breakthroughs 2Health News:Decreased total sleep time associated with increased REM sleep during subsequent naps 2Health News:Children with Down Syndrome sleep poorly and have more fragmented sleep 2Health News:Treatment at an AASM accredited sleep center improves long-term CPAP compliance 2Health News:Treatment at an AASM accredited sleep center improves long-term CPAP compliance 3
The Guidant Fineline EZ leads with protective capsule are bipolar endocardial and designed for permanent implantation with pulse generators for cardiac pacing....
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
... The Model 6491 unipolar ... designed for temporary atrial and ... and after cardiac surgery. This ... downsized, making it the ideal ...
... Guidant Flextend lead is ... lead with an extendable/retractable ... helix design offers various ... permanent implantation in the ...
Medicine Products: